Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
CKPT.US
id: 1076, Created by , Scout

Checkpoint Therapeutics (CKPT) FDA Refusal to Issue Treatment License Case

  • On December 18, 2023, Checkpoint (CKPT) announced that the FDA has denied Company’s biologic license application for a new treatment.
  • On it, $CKPT fell 44.88%, losing $34M+ of shareholder value.
  • Investors may have grounds to suspect Checkpoint of regulatory setbacks, which led to their losses.
On December 18, 2023, Checkpoint issued a press release announcing that the FDA has issued a complete response letter (‘CRL’) for the biologic license application (‘BLA’) for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.
  • The CRL only cites findings that arose during a multi-sponsor inspection of Checkpoint’s third-party contract manufacturing organization as approvability issues to address in a resubmission.
  • The Company’s President and CEO stated that “we believe we can address the feedback in a resubmission to enable marketing approval in 2024”.
On this news, $CKPT fell 44.88% and lost over $34 million of its market capitalization, seriously damaging shareholders.

Considering all the information, investors might have grounds to suspect Checkpoint of having regulatory problems delay FDA approval of a treatment for an indeterminate period, which led to their losses.

The case is already under investigation by at least one of the reputable law firms.
Alleged Offence
Misleading Statements
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
18 December 2023
Collecting participants…

Checkpoint Therapeutics Inc

Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with sol...

    Ticker
    CKPT.US
    ISIN
    US1628281073
    CIK
    1651407
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    95 Sawyer Road, Waltham, MA, United States, 02453